Compare · ASGN vs ASTH
ASGN vs ASTH
Side-by-side comparison of ASGN Incorporated (ASGN) and Astrana Health Inc. (ASTH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASGN and ASTH operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- ASGN is the larger of the two at $5.83B, about 2.6x ASTH ($2.21B).
- Over the past year, ASGN is down 60.5% and ASTH is up 64.2% - ASTH leads by 124.7 points.
- ASTH has been more active in the news (8 items in the past 4 weeks vs 2 for ASGN).
- ASGN has more recent analyst coverage (15 ratings vs 7 for ASTH).
- Company
- ASGN Incorporated
- Astrana Health Inc.
- Price
- $19.39-52.08%
- $41.22+4.21%
- Market cap
- $5.83B
- $2.21B
- 1M return
- -48.94%
- +10.33%
- 1Y return
- -60.53%
- +64.20%
- Industry
- Professional Services
- Professional Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- News (4w)
- 2
- 8
- Recent ratings
- 15
- 7
ASGN Incorporated
ASGN Incorporated provides professional staffing and IT solutions in the technology, digital, creative, engineering and life sciences fields across commercial and government sectors in the United States and internationally. The company operates through three segments: Apex, Oxford, and ECS. The Apex segment offers technology, digital, creative, scientific, engineering staffing, and consulting services to Fortune 1000 and mid-market commercial clients. The Oxford segment provides hard-to-find technology, digital, engineering, and life sciences staffing and consulting services in various skill and geographic markets. The ECS Segment delivers advanced solutions in cloud, cyber security, artificial intelligence, machine learning, application and IT modernization, and science and engineering. The company was formerly known as On Assignment, Inc. and changed its name to ASGN Incorporated in April 2018. ASGN Incorporated was incorporated in 1985 and is headquartered in Glen Allen, Virginia.
Latest ASGN
- ASGN Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Holman Jonathan S covered exercise/tax liability with 386 shares, decreasing direct ownership by 2% to 15,507 units (SEC Form 4) (for withholding tax)
- SEC Form 10-Q filed by ASGN Incorporated
- Director Dyer Joseph Wendell bought $24,992 worth of shares (1,112 units at $22.47), increasing direct ownership by 6% to 19,953 units (SEC Form 4)
- Chief Accounting Officer Cunningham Rose bought $25,054 worth of shares (1,125 units at $22.27), increasing direct ownership by 8% to 15,587 units (SEC Form 4)
- President Iyer Sadasivam bought $25,164 worth of shares (1,110 units at $22.67), increasing direct ownership by 2% to 61,905 units (SEC Form 4)
- Director Obermaier Patricia L bought $51,512 worth of shares (2,500 units at $20.61), increasing direct ownership by 35% to 9,548 units (SEC Form 4)
- EVP, Chief Financial Officer Perry Marie bought $100,018 worth of shares (5,350 units at $18.70), increasing direct ownership by 10% to 58,328 units (SEC Form 4)
- Director Lindstrom Carol bought $4,977 worth of shares (247 units at $20.15), increasing direct ownership by 2% to 11,558 units (SEC Form 4)
- Director Callaghan Brian J. bought $103,800 worth of shares (5,121 units at $20.27) (SEC Form 4)
Latest ASTH
- Director Schmidt David was granted 4,525 shares, increasing direct ownership by 14% to 36,019 units (SEC Form 4)
- Director Mazdyasni Matthew was granted 4,525 shares, increasing direct ownership by 13% to 39,288 units (SEC Form 4)
- Director Kitayama Mitchell W was granted 4,991 shares, increasing direct ownership by 18% to 32,837 units (SEC Form 4)
- Director Dong Linda was granted 4,525 shares, increasing direct ownership by 5% to 97,133 units (SEC Form 4)
- Director Dai, Weili was granted 4,525 shares, increasing direct ownership by 33% to 18,188 units (SEC Form 4)
- Director Chiang John was granted 4,525 shares, increasing direct ownership by 15% to 35,373 units (SEC Form 4)
- Astrana Health Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth
- Astrana Health upgraded by Barclays with a new price target
- COO and CFO Basho Chandan covered exercise/tax liability with 8,155 shares, decreasing direct ownership by 5% to 159,610 units (SEC Form 4) (tax withholding)